Literature DB >> 29097497

MDS1 and EVI1 complex locus (MECOM): a novel candidate gene for hereditary hematological malignancies.

Tim Ripperger1, Winfried Hofmann2, Jan C Koch3, Katayoon Shirneshan2,4, Detlef Haase4, Gerald Wulf4, Peter R Issing5, Matthias Karnebogen6, Gunnar Schmidt2, Bernd Auber2, Brigitte Schlegelberger2, Thomas Illig2,7, Birgit Zirn8, Doris Steinemann2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29097497      PMCID: PMC5792286          DOI: 10.3324/haematol.2017.178723

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A.

Authors:  N P Pavletich; C O Pabo
Journal:  Science       Date:  1991-05-10       Impact factor: 47.728

Review 2.  Keep your fingers off my DNA: protein-protein interactions mediated by C2H2 zinc finger domains.

Authors:  Kathryn J Brayer; David J Segal
Journal:  Cell Biochem Biophys       Date:  2008-02-06       Impact factor: 2.194

3.  How I diagnose and manage individuals at risk for inherited myeloid malignancies.

Authors: 
Journal:  Blood       Date:  2016-07-28       Impact factor: 22.113

4.  Targeting a DNA binding motif of the EVI1 protein by a pyrrole-imidazole polyamide.

Authors:  Yi Zhang; Géraldine Sicot; Xiaohui Cui; Marion Vogel; Charles A Wuertzer; Kimberly Lezon-Geyda; John Wheeler; Daniel A Harki; Katy A Muzikar; Daniel A Stolper; Peter B Dervan; Archibald S Perkins
Journal:  Biochemistry       Date:  2011-11-10       Impact factor: 3.162

5.  Activation of Evi1 inhibits cell cycle progression and differentiation of hematopoietic progenitor cells.

Authors:  O S Kustikova; A Schwarzer; M Stahlhut; M H Brugman; T Neumann; M Yang; Z Li; A Schambach; N Heinz; S Gerdes; I Roeder; T C Ha; D Steinemann; B Schlegelberger; C Baum
Journal:  Leukemia       Date:  2012-12-05       Impact factor: 11.528

6.  Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents.

Authors:  Marcin W Wlodarski; Shinsuke Hirabayashi; Victor Pastor; Jan Starý; Henrik Hasle; Riccardo Masetti; Michael Dworzak; Markus Schmugge; Marry van den Heuvel-Eibrink; Marek Ussowicz; Barbara De Moerloose; Albert Catala; Owen P Smith; Petr Sedlacek; Arjan C Lankester; Marco Zecca; Victoria Bordon; Susanne Matthes-Martin; Jonas Abrahamsson; Jörn Sven Kühl; Karl-Walter Sykora; Michael H Albert; Bartlomiej Przychodzien; Jaroslaw P Maciejewski; Stephan Schwarz; Gudrun Göhring; Brigitte Schlegelberger; Annámaria Cseh; Peter Noellke; Ayami Yoshimi; Franco Locatelli; Irith Baumann; Brigitte Strahm; Charlotte M Niemeyer
Journal:  Blood       Date:  2015-12-23       Impact factor: 22.113

7.  Mutations in MECOM, Encoding Oncoprotein EVI1, Cause Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia.

Authors:  Tetsuya Niihori; Meri Ouchi-Uchiyama; Yoji Sasahara; Takashi Kaneko; Yoshiko Hashii; Masahiro Irie; Atsushi Sato; Yuka Saito-Nanjo; Ryo Funayama; Takeshi Nagashima; Shin-Ichi Inoue; Keiko Nakayama; Keiichi Ozono; Shigeo Kure; Yoichi Matsubara; Masue Imaizumi; Yoko Aoki
Journal:  Am J Hum Genet       Date:  2015-11-12       Impact factor: 11.025

8.  Congenital thrombocytopenia in a neonate with an interstitial microdeletion of 3q26.2q26.31.

Authors:  Arjan Bouman; Lia Knegt; Stefan Gröschel; Claudia Erpelinck; Mathijs Sanders; Ruud Delwel; Taco Kuijpers; Jan Maarten Cobben
Journal:  Am J Med Genet A       Date:  2015-11-10       Impact factor: 2.802

9.  Mutation at the Evi1 locus in Junbo mice causes susceptibility to otitis media.

Authors:  Nicholas Parkinson; Rachel E Hardisty-Hughes; Hilda Tateossian; Hsun-Tien Tsai; Debra Brooker; Sue Morse; Zuzanna Lalane; Francesca MacKenzie; Martin Fray; Pete Glenister; Anne-Marie Woodward; Sian Polley; Ivana Barbaric; Neil Dear; Tertius A Hough; A Jackie Hunter; Michael T Cheeseman; Steve D M Brown
Journal:  PLoS Genet       Date:  2006-10-06       Impact factor: 5.917

10.  A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia.

Authors:  Stefan Gröschel; Mathijs A Sanders; Remco Hoogenboezem; Elzo de Wit; Britta A M Bouwman; Claudia Erpelinck; Vincent H J van der Velden; Marije Havermans; Roberto Avellino; Kirsten van Lom; Elwin J Rombouts; Mark van Duin; Konstanze Döhner; H Berna Beverloo; James E Bradner; Hartmut Döhner; Bob Löwenberg; Peter J M Valk; Eric M J Bindels; Wouter de Laat; Ruud Delwel
Journal:  Cell       Date:  2014-04-03       Impact factor: 41.582

View more
  9 in total

1.  Lethal neonatal bone marrow failure syndrome with multiple congenital abnormalities, including limb defects, due to a constitutional deletion of 3' MECOM.

Authors:  Lars T van der Veken; Merel C Maiburg; Floris Groenendaal; Mariëlle E van Gijn; Andries C Bloem; Claudia Erpelinck; Stefan Gröschel; Mathijs A Sanders; Ruud Delwel; Marc B Bierings; Arjan Buijs
Journal:  Haematologica       Date:  2018-02-08       Impact factor: 9.941

2.  Expanding the phenotypic and genetic spectrum of radioulnar synostosis associated hematological disease.

Authors:  Amanda Walne; Hemanth Tummala; Alicia Ellison; Shirleny Cardoso; Jasmin Sidhu; Gabriela Sciuccati; Tom Vulliamy; Inderjeet Dokal
Journal:  Haematologica       Date:  2018-03-08       Impact factor: 9.941

3.  Clinical and Genomic Profiles of Korean Patients with MECOM Rearrangement and the t(3;21)(q26.2;q22.1) Translocation.

Authors:  Jikyo Lee; Sung Min Kim; Soonok Kim; Jiwon Yun; Dajeong Jeong; Young Eun Lee; Eun-Youn Roh; Dong Soon Lee
Journal:  Ann Lab Med       Date:  2022-09-01       Impact factor: 4.941

Review 4.  Treatment of inherited thrombocytopenias.

Authors:  Carlo L Balduini
Journal:  Haematologica       Date:  2022-06-01       Impact factor: 11.047

5.  MECOM-associated syndrome: a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia.

Authors:  Manuela Germeshausen; Phil Ancliff; Jaime Estrada; Markus Metzler; Eva Ponstingl; Horst Rütschle; Dirk Schwabe; Richard H Scott; Sule Unal; Angela Wawer; Bernward Zeller; Matthias Ballmaier
Journal:  Blood Adv       Date:  2018-03-27

Review 6.  Advances in germline predisposition to acute leukaemias and myeloid neoplasms.

Authors:  Jeffery M Klco; Charles G Mullighan
Journal:  Nat Rev Cancer       Date:  2020-12-16       Impact factor: 60.716

Review 7.  Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies.

Authors:  Serine Avagyan; Akiko Shimamura
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

Review 8.  Multifaceted Role of PRDM Proteins in Human Cancer.

Authors:  Amelia Casamassimi; Monica Rienzo; Erika Di Zazzo; Anna Sorrentino; Donatella Fiore; Maria Chiara Proto; Bruno Moncharmont; Patrizia Gazzerro; Maurizio Bifulco; Ciro Abbondanza
Journal:  Int J Mol Sci       Date:  2020-04-10       Impact factor: 5.923

Review 9.  Molecular Pathogenesis in Myeloid Neoplasms with Germline Predisposition.

Authors:  Juehua Gao; Yihua Chen; Madina Sukhanova
Journal:  Life (Basel)       Date:  2021-12-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.